A Delhi-based pharma company has received the IP (intellectual property) of a path-breaking drug molecule for Alzheimer’s disease that scientists at the Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR) in Bengaluru developed more than a year ago.https://ift.tt/Af3zli4